Effect of ropinirole on visuo‐motor test in newly diagnosed Parkinson's disease patients
Identifieur interne : 001314 ( Main/Exploration ); précédent : 001313; suivant : 001315Effect of ropinirole on visuo‐motor test in newly diagnosed Parkinson's disease patients
Auteurs : S. Badarny [Israël] ; A. Stern [Israël] ; Z. Susel [Israël] ; S. Honigman [Israël] ; S. Hocherman [Israël]Source :
- Acta Neurologica Scandinavica [ 0001-6314 ] ; 2006-05.
English descriptors
- KwdEn :
Abstract
Objectives – The aim of this study was to assess the sensitivity of the visuo‐motor test (VMT) compared with the Unified Parkinson's Disease Rating Scale (UPDRS) in newly diagnosed Parkinson's disease (PD) patients. Methods – VMT and UPDRS were carried out in 20 patients before treatment onset, 2 weeks after treatment with ropinirole 1.5 mg/day and 2 weeks following increasing the dose of ropinirole to 3.0 mg/day. Results – Improvement in clinical status was seen in all patients, with a mean UPDRS reduction of 16.6% following treatment with ropinirole 1.5 mg/day, and 38.9% reduction in UPDRS observed with ropinirole 3.0 mg/day. Initial improvement was not correlated with severity of PD, although further improvement with ropinirole 3.0 mg/day correlated linearly with patient's baseline UPDRS. Improvement in the ability to control the direction of the moving hand during tracing is expressed by the reduction of VMT variables following treatment. Mean VMT variables were 36.2% at baseline, 34.0% with ropinirole 1.5 mg/day and 31.7% with ropinirole 3.0 mg/day. Although changes in VMT variables were less uniform across patients, on average, it did correlate with patients UPDRS. Conclusions – We suggest that VMT can be useful in the assessment of treatment effect on high‐level motor planning and cognitive capabilities in newly diagnosed PD patients, added to the UPDRS which does not appropriately comply with those skills.
Url:
DOI: 10.1111/j.1600-0404.2006.00601.x
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effect of ropinirole on visuo‐motor test in newly diagnosed Parkinson's disease patients</title><author><name sortKey="Badarny, S" sort="Badarny, S" uniqKey="Badarny S" first="S." last="Badarny">S. Badarny</name></author><author><name sortKey="Stern, A" sort="Stern, A" uniqKey="Stern A" first="A." last="Stern">A. Stern</name></author><author><name sortKey="Susel, Z" sort="Susel, Z" uniqKey="Susel Z" first="Z." last="Susel">Z. Susel</name></author><author><name sortKey="Honigman, S" sort="Honigman, S" uniqKey="Honigman S" first="S." last="Honigman">S. Honigman</name></author><author><name sortKey="Hocherman, S" sort="Hocherman, S" uniqKey="Hocherman S" first="S." last="Hocherman">S. Hocherman</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:D9E35D30D251F4615A1F65D3421626A3ED67B91D</idno><date when="2006" year="2006">2006</date><idno type="doi">10.1111/j.1600-0404.2006.00601.x</idno><idno type="url">https://api.istex.fr/document/D9E35D30D251F4615A1F65D3421626A3ED67B91D/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">002405</idno><idno type="wicri:Area/Main/Curation">002079</idno><idno type="wicri:Area/Main/Exploration">001314</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Effect of ropinirole on visuo‐motor test in newly diagnosed Parkinson's disease patients</title><author><name sortKey="Badarny, S" sort="Badarny, S" uniqKey="Badarny S" first="S." last="Badarny">S. Badarny</name><affiliation wicri:level="1"><country xml:lang="fr">Israël</country><wicri:regionArea>Movement Disorders Clinic, Department of Neurology, Carmel Medical Center, Haifa</wicri:regionArea><wicri:noRegion>Haifa</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Israël</country><wicri:regionArea>Faculty of Medicine, Technion – Israel Institute of Technology, Haifa</wicri:regionArea><wicri:noRegion>Haifa</wicri:noRegion></affiliation></author><author><name sortKey="Stern, A" sort="Stern, A" uniqKey="Stern A" first="A." last="Stern">A. Stern</name><affiliation wicri:level="1"><country xml:lang="fr">Israël</country><wicri:regionArea>Movement Disorders Clinic, Department of Neurology, Carmel Medical Center, Haifa</wicri:regionArea><wicri:noRegion>Haifa</wicri:noRegion></affiliation></author><author><name sortKey="Susel, Z" sort="Susel, Z" uniqKey="Susel Z" first="Z." last="Susel">Z. Susel</name><affiliation wicri:level="1"><country xml:lang="fr">Israël</country><wicri:regionArea>Movement Disorders Clinic, Department of Neurology, Carmel Medical Center, Haifa</wicri:regionArea><wicri:noRegion>Haifa</wicri:noRegion></affiliation></author><author><name sortKey="Honigman, S" sort="Honigman, S" uniqKey="Honigman S" first="S." last="Honigman">S. Honigman</name><affiliation wicri:level="1"><country xml:lang="fr">Israël</country><wicri:regionArea>Movement Disorders Clinic, Department of Neurology, Carmel Medical Center, Haifa</wicri:regionArea><wicri:noRegion>Haifa</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Israël</country><wicri:regionArea>Faculty of Medicine, Technion – Israel Institute of Technology, Haifa</wicri:regionArea><wicri:noRegion>Haifa</wicri:noRegion></affiliation></author><author><name sortKey="Hocherman, S" sort="Hocherman, S" uniqKey="Hocherman S" first="S." last="Hocherman">S. Hocherman</name><affiliation wicri:level="1"><country xml:lang="fr">Israël</country><wicri:regionArea>Faculty of Medicine, Technion – Israel Institute of Technology, Haifa</wicri:regionArea><wicri:noRegion>Haifa</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Acta Neurologica Scandinavica</title><idno type="ISSN">0001-6314</idno><idno type="eISSN">1600-0404</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2006-05">2006-05</date><biblScope unit="volume">113</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="294">294</biblScope><biblScope unit="page" to="300">300</biblScope></imprint><idno type="ISSN">0001-6314</idno></series><idno type="istex">D9E35D30D251F4615A1F65D3421626A3ED67B91D</idno><idno type="DOI">10.1111/j.1600-0404.2006.00601.x</idno><idno type="ArticleID">ANE601</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0001-6314</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term><term>ropinirole</term><term>visuo‐motor test</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Objectives – The aim of this study was to assess the sensitivity of the visuo‐motor test (VMT) compared with the Unified Parkinson's Disease Rating Scale (UPDRS) in newly diagnosed Parkinson's disease (PD) patients. Methods – VMT and UPDRS were carried out in 20 patients before treatment onset, 2 weeks after treatment with ropinirole 1.5 mg/day and 2 weeks following increasing the dose of ropinirole to 3.0 mg/day. Results – Improvement in clinical status was seen in all patients, with a mean UPDRS reduction of 16.6% following treatment with ropinirole 1.5 mg/day, and 38.9% reduction in UPDRS observed with ropinirole 3.0 mg/day. Initial improvement was not correlated with severity of PD, although further improvement with ropinirole 3.0 mg/day correlated linearly with patient's baseline UPDRS. Improvement in the ability to control the direction of the moving hand during tracing is expressed by the reduction of VMT variables following treatment. Mean VMT variables were 36.2% at baseline, 34.0% with ropinirole 1.5 mg/day and 31.7% with ropinirole 3.0 mg/day. Although changes in VMT variables were less uniform across patients, on average, it did correlate with patients UPDRS. Conclusions – We suggest that VMT can be useful in the assessment of treatment effect on high‐level motor planning and cognitive capabilities in newly diagnosed PD patients, added to the UPDRS which does not appropriately comply with those skills.</div></front></TEI><affiliations><list><country><li>Israël</li></country></list><tree><country name="Israël"><noRegion><name sortKey="Badarny, S" sort="Badarny, S" uniqKey="Badarny S" first="S." last="Badarny">S. Badarny</name></noRegion><name sortKey="Badarny, S" sort="Badarny, S" uniqKey="Badarny S" first="S." last="Badarny">S. Badarny</name><name sortKey="Hocherman, S" sort="Hocherman, S" uniqKey="Hocherman S" first="S." last="Hocherman">S. Hocherman</name><name sortKey="Honigman, S" sort="Honigman, S" uniqKey="Honigman S" first="S." last="Honigman">S. Honigman</name><name sortKey="Honigman, S" sort="Honigman, S" uniqKey="Honigman S" first="S." last="Honigman">S. Honigman</name><name sortKey="Stern, A" sort="Stern, A" uniqKey="Stern A" first="A." last="Stern">A. Stern</name><name sortKey="Susel, Z" sort="Susel, Z" uniqKey="Susel Z" first="Z." last="Susel">Z. Susel</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001314 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001314 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:D9E35D30D251F4615A1F65D3421626A3ED67B91D
|texte= Effect of ropinirole on visuo‐motor test in newly diagnosed Parkinson's disease patients
}}
| This area was generated with Dilib version V0.6.23. |  |